KOPRAN : EU GMP INSPECTION AT KHOPOLI FACILITY CLOSES WITH NO CRITICAL OBSERVATIONS

• EU Medicine Authority conducted the GMP inspection at the company's Khopoli formulation manufacturing facility from September 18 to September 23, 2026 • Inspection concluded with no critical observations, one major observation and some minor observations • No data integrity related observations were reported • Company is in the process of submitting compliance responses to the EU authorities within a fortnight

Kopran Ltd

Open attachment

← Back to feed